Public preview. Funding rounds, founders, and growth signals require a free account.

Evox Therapeutics

Evox Therapeutics develops exosome-based gene therapies for neurodegenerative diseases using a proprietary CRISPR editor platform designed to deliver genetic medicine to the brain. The company's ExoEdit platform combines exosome technology with gene editing to address genetic causes of neurodegeneration with improved safety and scalability.

Other11-50 employees

Status

Active

Founders & team

Co-founder, CEO

Co-founder, CTO

Head of Engineering

Head of Sales

🔒

Sign up to see founders

Free account unlocks founder names, LinkedIn profiles, and prior companies.

Create free account

Growth signals

Web traffic

Search interest

Social followers

Glassdoor rating

News mentions

Gov contracts

🔒

Sign up to see signals

Free account unlocks 5 full profiles per day. Pro removes the limit.

Create free account

Track Evox Therapeutics on FlareSight

Get notified the moment Evox Therapeutics files a new round, hires execs, or shows traction signals.

Create free account

About this data

FlareSight surfaces funding data from SEC Form D filings within hours of submission. Browse our full startup funding database to find more recently funded companies.